- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Profitable Climbers
Japanese Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Sawai Group Holdings
Market Cap: JP¥279.0b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥2,416.00
7D
1.2%
1Y
20.0%
Kidswell Bio
Market Cap: JP¥13.7b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥277.00
7D
9.5%
1Y
166.3%